نتائج البحث 81-90 من 15911 لعملية البحث عن B cell lymphomas
... B) of CA-4948 in patients with RR NHL with and without myeloid ... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral ...
Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas ... B Cell Lymphoma (DLBCL), Hodgkin Lymphoma (HL) and Post-transplant ...
... B-Cell Lymphoma (DLBCL). Rochester, Minn. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI ...
... B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL). Jacksonville, Fla. The purpose of ...
... lymphoma who are in clinical remission. Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma.
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study to Evaluate 68Ga- PSMA-Dual ...
... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...
... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral ... A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.